| P2093 | author name string | Luigi Biancone | |
| | Andrea Ranghino | |
| | Giuseppe Paolo Segoloni | |
| | Fedele Lasaponara | |
| P2860 | cites work | Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials | Q26823281 |
| | Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C | Q28266440 |
| | Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists | Q29618071 |
| | Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates | Q30090232 |
| | Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials | Q33371189 |
| | The estimation of post-transplant lymphocele origin using creatine kinase activity | Q34128124 |
| | Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. | Q34251293 |
| | Markers for microscopic imaging of lymphangiogenesis and angiogenesis | Q34656435 |
| | The human renal lymphatics under normal and pathological conditions | Q35105802 |
| | FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors | Q36160378 |
| | The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesis. | Q36241051 |
| | The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants | Q36270373 |
| | Arnold Heller and the lymph pump | Q36283784 |
| | Lymphangiogenesis in development and human disease | Q36342355 |
| | Urological complications in renal transplantation. | Q36463075 |
| | FTY720 (fingolimod) in renal transplantation. | Q36652022 |
| | Sphingosine 1-phosphate receptor modulators: a new class of immunosuppressants. | Q36652104 |
| | Molecular biology and pathology of lymphangiogenesis | Q37014851 |
| | Lymphocele after kidney transplantation: where are we standing now? | Q37282508 |
| | Lymphangiogenesis: in vitro and in vivo models | Q37591047 |
| | Does rejection have a role in lymphocele formation post renal transplantation? A single centre experience | Q37793866 |
| | Lymphocele after renal transplantation, a medical complication | Q37900239 |
| | Management of primary symptomatic lymphocele after kidney transplantation: a systematic review | Q37919325 |
| | Laparoscopic treatment of lymphoceles after renal transplantation | Q38007292 |
| | The outcomes of treatment and the etiology of lymphoceles with a focus on hemostasis in kidney recipients: a preliminary report | Q39204325 |
| | Lymphocytes associated with renal transplantation. Report of 15 cases and review of the literature | Q39950773 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Lymphocele after kidney transplantation. | Q40434189 |
| | Graft loss due to percutaneous sclerotherapy of a lymphocele using acetic acid after renal transplantation | Q40502383 |
| | Renal cortical interstitium and fluid absorption by peritubular capillaries | Q40732179 |
| | Does Increased Serum Creatine Kinase Activity Reflect Exercise-Induced Muscle Damage in Rats? | Q41681169 |
| | Prevention of lymphoceles following renal transplantation | Q41907816 |
| | The crucial role of macrophages in lymphangiogenesis | Q41945366 |
| | Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose fingolimod (FTY720) in adolescents with stable renal transplants | Q42601315 |
| | FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study | Q42632363 |
| | Complicated lymphoceles after kidney transplantation | Q42776146 |
| | Post–Kidney Transplantation Lymphocele due to a Lymphatic Filariasis | Q42910469 |
| | Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial | Q43054847 |
| | Minimally invasive methods for the treatment of lymphocele after kidney transplantation | Q43254710 |
| | Is lymphocele in renal transplantation an avoidable complication? | Q73825972 |
| | Lymphatic neoangiogenesis in human renal allografts: results from sequential protocol biopsies | Q79731731 |
| | Lymphocele following renal transplantation | Q79767480 |
| | Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis | Q79772239 |
| | The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation | Q79907943 |
| | Lymphatic leakage in a renal transplant: The role of lymphoscintigraphy | Q79949760 |
| | Assessment of lymphocele incidence following 450 renal transplantations | Q81395232 |
| | Effect of manual lymph drainage on the course of serum levels of muscle enzymes after treadmill exercise | Q83820438 |
| | Octreotide in the treatment of lymphorrhea after renal transplantation: a preliminary experience | Q83937500 |
| | FTY720/cyclosporine regimens in de novo renal transplantation: a 1-year dose-finding study | Q83984696 |
| | Technical aspects of unilateral dual kidney transplantation from expanded criteria donors: experience of 100 patients | Q84574178 |
| | Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration | Q43283119 |
| | Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients | Q44168474 |
| | Sirolimus and lymphocele formation after kidney transplantation: an immunosuppressive medication as co-factor for a surgical problem? | Q44288747 |
| | Angiotensin II, diuretics, and thoracic duct lymph flow in the dog. | Q44521457 |
| | Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients? | Q44570490 |
| | Retransplantation as a risk factor for lymphocele formation | Q44765746 |
| | Lymphedema associated with sirolimus in renal transplant recipients. | Q44846974 |
| | FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation | Q44956732 |
| | Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus | Q44967971 |
| | Impact of donor kidney recovery method on lymphatic complications in kidney transplantation | Q44973318 |
| | A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus | Q45214571 |
| | Incidence of delayed graft function and wound healing complications after deceased-donor kidney transplantation is not affected by de novo everolimus. | Q45936354 |
| | Management of side effects of sirolimus therapy | Q46041711 |
| | A systematic approach to minimizing wound problems for de novo sirolimus-treated kidney transplant recipients | Q46155732 |
| | Steroid withdrawal five days after renal transplantation allows for the prevention of wound-healing complications associated with sirolimus therapy | Q46411060 |
| | Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy | Q46452714 |
| | Surgical complications after renal transplantation in grafts with multiple arteries | Q46475812 |
| | Intraoperative placing of drains decreases the incidence of lymphocele and deep vein thrombosis after renal transplantation | Q46812046 |
| | Reduced exposure to calcineurin inhibitors in renal transplantation | Q46840533 |
| | Did volume of lymphocele after kidney transplantation determine the choice of treatment modality? | Q46894271 |
| | FTY720 versus mycophenolate mofetil in de novo renal transplantation: six-month results of a double-blind study | Q46913111 |
| | Instillation of povidone iodine to treat lymphocele and leak of lymph after renal transplantation. | Q46938825 |
| | Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation | Q47177193 |
| | Does ultrasonic energy for surgical dissection reduce the incidence of renal transplant lymphocele? | Q50985003 |
| | Post-transplant lymphoceles: a critical look into the risk factors, pathophysiology and management. | Q51051433 |
| | A method for studying lymphatic pumping activity in conscious and anaesthetized sheep. | Q51208150 |
| | Influence of Long-Term Dialysis Treatment on Operative Complications After Renal Transplantation | Q51542809 |
| | The natural history of and therapy for perirenal fluid collections following renal transplantation. | Q52552203 |
| | Impact of surgeon experience on complication rates and functional outcomes of 484 deceased donor renal transplants: a single-centre retrospective study. | Q52889226 |
| | A pathological analysis of lymphatic vessels in early renal allograft. | Q53582271 |
| | Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. | Q53640436 |
| | Wound events in kidney transplant patients receiving de novo everolimus: a pooled analysis of three randomized controlled trials | Q57793035 |
| | Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study | Q57943257 |
| | Management of lymphoceles after kidney transplantation | Q62517980 |
| | FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. | Q64904400 |
| | The role of renal lymph in hydronephrosis | Q67043036 |
| | Frequency and clinical influence of lymphoceles after kidney transplantation | Q68535756 |
| | Accumulation of Lymph Around the Transplanted Kidney (Lymphocele) Mimicking Renal Allograft Rejection | Q69315613 |
| | Microradiographic demonstration of human intrarenal microlymphatic pathways | Q69671906 |
| | Percutaneous management of postoperative lymphocele | Q69764740 |
| | Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg | Q71425315 |
| | Renal lymphatic function following venous pressure elevation | Q71572999 |
| | The lymphatics of the kidney and the formation of renal lymph | Q71851522 |
| | Adult polycystic kidney disease: a risk factor for lymphocele formation after renal transplantation? | Q72003592 |
| | Laparoscopic drainage of lymphoceles after kidney transplantation: indications and limitations | Q72600335 |
| | Intrinsic rhythmic propulsion of lymph in the unanaesthetized sheep | Q72631688 |
| | Technical complications of renal transplantation | Q72753040 |
| | Lymphocele: a possible relationship with acute cellular rejection in kidney transplantation | Q73334845 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 615-22 | |
| P577 | publication date | 2015-10-01 | |
| P1433 | published in | Clinical kidney journal / an academic journal of the ERA-EDTA (European Renal Association - European Dialysis and Transplant Association) | Q26842221 |
| P1476 | title | Lymphatic disorders after renal transplantation: new insights for an old complication | |
| P478 | volume | 8 | |